Issue 14 - From Brain Tumours to MS: Cannabis Unleashes Its Medical Might!

BudMed Bulletin for 12 December 24

Revolutionizing Brain Cancer Treatment: How Nanotech is Supercharging Cannabinoids Against Glioblastoma! 

Nano carriers improve cannabinoid delivery to brain tumours by enhancing solubility, stability, and targeting, allowing better penetration across the blood-brain barrier. Source

Cannabis: Discover How This Green Ally Fights Breast, Colorectal, and Prostate Cancer! 

THC and another cannabis compound slowed tumour growth. For colorectal cancer, CBD can kill off chemo-resistant cells, stop cancer from spreading by blocking a specific receptor, and reduce blood vessel formation that tumours need to grow, while also reducing inflammation. Source

Discover How Low-Dose CBD Might Shield Your Liver During Intense Workouts!

Conclusions: Short-term use of 60 mg CBD daily might help reduce liver stress from heavy exercise. There was no evidence that taking 60 mg CBD daily for a week would harm the liver. Source

Cannabidiol (CBD) Proves to Rapidly Halt Seizures in Tough-to-Treat Epilepsy Cases!

EMAS is an early childhood epilepsy that can become drug-resistant but may improve after three years. CBD, specifically Epidiolex®, has proven effective, with two cases showing seizure freedom in 7-30 days, suggesting it could be used alone to treat EMAS. Source

Stunning Discovery: Could CBD Work Its Magic on Brain Cancer 

The study found that CBD can influence the creation of brain cancer cells (BMCs) in glioblastoma (GBM). When GBM tissues were treated with CBD, there was a notable increase in a protein called TIAR-1, which also led to higher levels of eIF2α and its phosphorylated form. This suggests that inhaling CBD could enhance the formation of stress granules (SGs) in GBM, pointing towards a new treatment strategy by targeting these cancer cells. Source

MS Breakthrough: Cannabinoids Slash Spasticity! 

Study Reveals Nabiximols as Game-Changer - Significantly Reduces Symptoms! "The results of this systematic review and meta-analysis showed that nabiximols was the most common cannabinoid which was used to control MS-related spasticity, and it was effective in controlling MS-related spasticity (significantly decreased SMD of NRS, and Ashworth after treatment)." Source

If you received this from a friend and want to subscribe, go here Subscribe to the BudMed Bulletin. You can also follow me on:

X at @marclanders

Subscribe to my YouTube channel

Instagram

Tik Tok

Rumble

Disclaimer: The content provided in this newsletter by BudMed Bulletin is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition or the use of medical cannabis.